Investor Ideas Potcasts #Cannabis News and Stocks on the Move: (TSX: $APHA.TO) (NYSE: $APHA), (TSX-V: $WL.V) (CSE: $LHS.C) (OTCQX: $LHSIF), (CSE: $MPX.C) (OTC: $MPXEF) (CSE: $IAN.C) (OTCQX: $ITHUF)
Delta, Kelowna, BC - February 1, 2019 (Investorideas.com Newswire) www.Investorideas.com, a global news source covering leading sectors including marijuana and hemp stocks and its potcast site, www.potcasts.ca release today's edition of Investorideas.com potcastsCM - cannabis news and stocks to watch plus insight from thought leaders and experts.
Listen to the podcast:
Investor Ideas Potcasts #Cannabis News and Stocks on the Move: (TSX: $APHA.TO) (NYSE: $APHA), (TSX-V: $WL.V) (CSE: $LHS.C) (OTCQX: $LHSIF), (CSE: $MPX.C) (OTC: $MPXEF) (CSE: $IAN.C) (OTCQX: $ITHUF)
Hear Investor ideas cannabis potcast on iTunes
Today's podcast overview/transcript:
Good afternoon and welcome to another Investorideas.com "potcast", looking at cannabis news, stocks to watch as well as insights from thought leaders and experts.
Today we are looking at announcements from Aphria Inc. (TSX: APHA) (NYSE: APHA), Westleaf Inc. (TSX-V: WL), Liberty Health Sciences Inc. (CSE: LHS) (OTCQX: LHSIF), MPX Bioceutical Corporation (CSE: MPX) (OTC: MPXEF) and iAnthus Capital Holdings, Inc. (CSE: IAN) (OTCQX: ITHUF).
Aphria Inc. announced that it has completed its first transfer of plant cuttings from four of the Company's cannabis strains to Denmark-based Schroll Medical, as part of the Company's previously announced Strategic Partnership with Schroll. The shipment was completed under permits issued by the relevant health authorities, including an export permit from Health Canada, an import permit from the Danish Medicines Agency and a phytosanitary certificate from the Canadian Food Inspection Agency.
"We are pleased to introduce the first four Aphria strains to be produced in Europe, through our strategic alliance with Schroll," said Hendrik Knopp, Managing Director of Aphria Germany, who is overseeing the Partnership on behalf of Aphria and Schroll. "This marks another important milestone for Aphria as we extend our leadership position in the European market, and it gives me joy to be able to say today that we literally have a good thing growing in Europe."
Westleaf Inc. announced the closing of two recently announced acquisitions, which support its strategy of acquiring premium assets across the cannabis value chain. The transactions were previously announced on January 24, 2019 and January 28, 2019, respectively.
- Closing of Option - Canndara Canada Inc. Westleaf has closed the acquisition of all the issued and outstanding shares of Canndara, for an aggregate purchase price of $48.4 million. The purchase price was paid by the issuance of an aggregate of 21,641,407 common shares in the capital of Westleaf at a deemed value of $2.24 per Common Share. The transaction includes maintaining Canndara's founders as part of the senior management team, each having entered into a voluntary 24-month pooling agreement.
- Closing of Definitive Agreement - Delta 9 Cannabis Inc. Westleaf has also closed its previously announced acquisition of Delta 9's 50% interest in the Delta West extraction facility, bringing Westleaf's total ownership to 100%. The purchase price was paid by way of the payment of $1 million and the issuance of an aggregate of 5,600,000 Common Shares to Delta 9 that, based on the closing price of the Common Shares on the TSX Venture Exchange of $2.67 per Common Share on January 25, 2019, represents an aggregate purchase price of approximately $14.95 million.
Liberty Health Sciences Inc., a provider of high quality cannabis, announced today that The British Standards Institution (BSI) has awarded a Good Manufacturing Practice (GMP) certificate to Liberty Health Sciences medical cannabis manufacturing facility, located at Liberty 360 Innovation Campus property in Gainesville, FL. Certification for this facility indicates that it also meets all of the Florida Department of Health (DOH) requirements pertaining to the processing, extraction and production of medical cannabis.
"Receiving GMP certification at an additional facility is a major milestone for Liberty Health Sciences and it demonstrates our commitment to producing the highest quality and safest products possible for our customers throughout the state of Florida," said George Scorsis, CEO of Liberty Health Sciences. "This achievement reflects the incredibly high standards we expect of ourselves and that our clients expect as a patient provider. We will continue to produce the highest quality products and exceed production standards that surpass even the most stringent regulatory requirements."
iAnthus Capital Holdings, Inc. and MPX Bioceutical Corporation jointly announced that the previously announced plan of arrangement under the Business Corporations Act pursuant to which iAnthus will acquire all of the issued and outstanding common shares of MPX pursuant to the terms of an Arrangement Agreement between iAnthus and MPX dated October 18, 2018 is now expected to close on or before February 5, 2019. Both parties and their respective advisors are working in close collaboration to ensure the imminent closing of the transaction.
Further information about the closing of the Arrangement is available on the SEDAR profiles of iAnthus and MPX at www.sedar.com.
Subscribe to the new cannabis podcast series:
To hear more Investorideas.com podcasts visit: https://www.investorideas.com/Audio/.
Investorideas.com podcasts are also available on iTunes, Spotify, Google Play Music, Stitcher, Spreaker, YouTube via Spreaker, iHeartradio and Tunein.
Potcasts is now a certified word mark Trademark on the blockchain through Cognate, Inc. CM Certification-Registration Number: 10468217708
Get the cannabis/hemp stock directory as an Investor ideas member , plus get weekly updates with new pot stocks added and get the daily potcast for Investor Ideas #Potcasts #Cannabis News and Stocks on the Move. Learn more https://www.investorideas.com/membership/
About Investorideas.com - News that Inspires Big Investing Ideas
Investorideas.com is a recognized news source publishing third party news and press releases plus we create original financial content. Learn about investing in stocks and sector trends from Investorideas.com with our news alerts , articles , podcasts and videos talking about cannabis, crypto, technology including AI and IoT , mining ,sports biotech, water, renewable energy and more . Investorideas.com original branded content includes the daily Crypto Corner and Podcast, Play by Play sports and stock news column, Investor Ideas #Potcasts#Cannabis News and Stocks on the Move podcast and column, Cleantech and Climate Change Podcast and the AI Eye Podcast and column covering developments in AI.
Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investment involves risk and possible loss of investment. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Contact each company directly regarding content and press release questions. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers.
Learn more about Investor ideas podcast and news publication services and costs https://www.investorideas.com/News-Upload/
Additional info regarding BC Residents and global Investors: Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: https://www.bcsc.bc.ca/release.aspx?id=6894. Global investors must adhere to regulations of each country.
Please read Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp
Investor Ideas does not condone the use of cannabis except where permissible by law. Our site does not possess, distribute, or sell cannabis products.
Investor ideas reminds all listeners to read our disclaimers and disclosures on the Investorideas.com website and this podcast is not an endorsement to buy products or services or securities. Investors are reminded all investment involves risk and possible loss of investment
Follow us on Social Media
Contact Investorideas.com
800-665-0411
No comments:
Post a Comment